FDA Orange Book · active-ingredient family
Etoposide phosphate
Etoposide phosphate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ETOPOPHOS PRESERVATIVE FREE · NDA 020457
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ETOPOPHOS PRESERVATIVE FREERLD | CHEPLAPHARM | NDA 020457 | — | May 17, 1996 | |
| ETOPOPHOS PRESERVATIVE FREE×2 | BRISTOL MYERS SQUIBB | NDA 020906 | — | Feb 27, 1998 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Etoposide phosphate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

